Article Listing - Gedeon Richter sees product mix improve in 2002

ICH STEERING COMMITTEE MEETING

6 April 1992

The Steering Committee for the Second International Conference on Harmonization (ICH) of technical requirements for the registration of pharmaceutical products...

STOCK MARKET COMMENTARY: TOKYO

6 April 1992

TOKYO: stocks declined last week after a brief hiatus. The Nikkei Average fell 2.8% to 19,669.311, once again below the...

AUSTRALIAN LAUNCH OF ROCHE'S AURORIX

6 April 1992

Hoffmann-La Roche's reversible inhibitor of monoamine oxidase type A, Aurorix (moclobemide) has now been launched in Australia. The novel antidepressant...

COMPANY NEWS FROM CHINA

6 April 1992

The Shanghai Medicines and Health Products Import and Export Corporation of China exported products worth $150 million in 1991, reports...

NEW PRES AT RHONE-POULENC RORER

6 April 1992

Rhone-Poulenc Rorer Inc has named Manfred Karobath as senior vice president, RPR, and president, RPR Research and Development. He was...

NEW PRES AT PROCORDIA

6 April 1992

Jan Ekberg has been named as president and chief executive at Procordia, in succession to Soren Gyll who has become...

PHARMA COs TOP R&D SPEND IN JAPAN

6 April 1992

Of 16 Japanese companies planning to spend over 10% of their sales on R&D in 1992, nine are pharmaceutical companies,...

AUSTRALIAN LAUNCH OF ROCHE'S AURORIX

6 April 1992

Hoffmann-La Roche's reversible inhibitor of monoamine oxidase type A, Aurorix (moclobemide) has now been launched in Australia. The novel antidepressant...

AMA REPORT ON CONTRACEPTIVES

6 April 1992

The outcome of a report from the American Medical Association's Board of Trustees concludes that long-acting contraceptives may be medically...

ICN-GALENIKA "HEALTHY SHARES"

6 April 1992

Yugoslavia's Tanjug news agency reports that Milan Panic, head of ICN-Galenika and founder of US-based ICN Pharmaceuticals, is saying the...

Showing 94491-94500 of 95341 articles